HYPMY
$6.11
Hypermarcas ADR
$.07
1.19%
HYPMY
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Friday
Dec 18
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when HYPMY reports earnings?
Beat
Meet
Miss

Where is HYPMY's stock price going from here?
Up
Flat
Down
Stock chart of HYPMY
Analysts
Summary of analysts' recommendations for HYPMY
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.